Hengqi Liu

机构：Tianjin Medical University Cancer Institute and Hospital

发表论文 16 篇 · 总被引 66 次 · h-index 4

代表论文

• Tracking the evolution of untreated high‐intermediate/high‐risk diffuse large B‐cell lymphoma by circulating tumour DNA (2021 · British Journal of Haematology · 被引 20)
• Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers (2024 · European Journal of Cancer · 被引 18)
• Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma (2024 · British Journal of Haematology · 被引 10)
• Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma (2023 · British Journal of Haematology · 被引 9)
• Metabolic pathway‐based subtyping reveals distinct microenvironmental states associated with diffuse large B‐cell lymphoma outcomes (2024 · Hematological Oncology · 被引 4)
• Single-cell and bulk transcriptomics reveal a CD8+ T-cell gene signature predicting prognosis in diffuse large B-cell lymphoma (2025 · Frontiers in Immunology · 被引 2)